NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A
Frequently Asked Questions
What is Market Cap of NKGen Biotech Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. NKGen Biotech Inc market cap is $7.84M.
What is the 52-week high for NKGen Biotech Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NKGen Biotech Inc 52 week high is $0.3299 as of July 21, 2026.
What is the 52-week low for NKGen Biotech Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NKGen Biotech Inc 52 week low is $0.0002 as of July 21, 2026.
What is NKGen Biotech Inc stock price today?
NKGen Biotech Inc stock price today is $0.06.
What was NKGen Biotech Inc stock price yesterday?
NKGen Biotech Inc stock price yesterday was $0.06.
What is the 50-day moving average of NKGen Biotech Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. NKGen Biotech Inc 50-day moving average is $0.0625.